Vimarsana
Biggest News Aggregation in the World

Noah Konig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Noah Konig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Noah Konig Today - Breaking & Trending Today

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area - Vimarsana News

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area

Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug ...

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled ... - Vimarsana News

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled ...

Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline - Vimarsana News

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments With this partnership, Absci achieves 2023 outlook of ten...

Congenica Receives CE Mark for Genomic Analysis Software - Vimarsana News

Congenica Receives CE Mark for Genomic Analysis Software

Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom - 202 1 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people's lives, today announces that its genomic interpretation software is now CE marked under the In Vitro Diagnostics Directive (98/79/EC). With the In Vitro Diagnostic (IVD) designation, Congenica's clinical decision support platform can make the transition from research to clinical use and be applied to the clinical diagnosis of patients with rare hereditary genomic disorders. The plat...